Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans

Mark S. Kleven, Wouter Koek

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Anxiolytic drugs generally produce anticonflict effects in both pigeons and rats, although relatively few anxiolytics have been examined in the pigeon and the procedure has not been as completely validated as the rat model. In this study, we examined the antipunishment effects of a variety of benzodiazepine agonists in pigeons and compared the relationship between their potencies to engender anxiolytic-like effects and their clinical doses in humans. In pigeons whose responding was maintained under a multiple FR30(food): FR30(foot+shock) schedule, the benzodiazepine agonists diazepam, flunitrazepam, alprazolam, chlordiazepoxide, lorazepam, flurazepam, bromazepam, medazepam, and clorazepate produced dose-related increases in punished responding, and, with the exception of medazepam, decreased unpunished responding at higher doses. Potencies calculated from the percentage of pigeons showing significant increases in punished responding ranged from 0.081 to 11 mg/kg, and these potencies were invariably lower than those for decreases in unpunished responding by factors ranging from 2.2 to more than 14. The comparison of relative potencies of benzodiazepine receptor agonists in pigeons and humans revealed a high positive correlation (0.90, P<0.005), thus demonstrating the predictive validity of this preclinical animal model for anxiolytic benzodiazepines. The results agree with previous findings of robust anticonflict effects of benzodiazepine receptor agonists and extend further the pharmacological characterization to compounds that have not been examined previously in pigeons.

Original languageEnglish (US)
Pages (from-to)206-212
Number of pages7
JournalPsychopharmacology
Volume141
Issue number2
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Columbidae
Benzodiazepines
Anti-Anxiety Agents
Medazepam
GABA-A Receptors
Bromazepam
Flurazepam
Alprazolam
Flunitrazepam
Chlordiazepoxide
Lorazepam
Diazepam
Foot
Shock
Appointments and Schedules
Animal Models
Pharmacology
Food
Pharmaceutical Preparations

Keywords

  • Anxiolytic
  • Conflict behavior
  • Pigeon

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans. / Kleven, Mark S.; Koek, Wouter.

In: Psychopharmacology, Vol. 141, No. 2, 1999, p. 206-212.

Research output: Contribution to journalArticle

@article{85b27e4b856a4cff89c6b6f44e444c64,
title = "Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans",
abstract = "Anxiolytic drugs generally produce anticonflict effects in both pigeons and rats, although relatively few anxiolytics have been examined in the pigeon and the procedure has not been as completely validated as the rat model. In this study, we examined the antipunishment effects of a variety of benzodiazepine agonists in pigeons and compared the relationship between their potencies to engender anxiolytic-like effects and their clinical doses in humans. In pigeons whose responding was maintained under a multiple FR30(food): FR30(foot+shock) schedule, the benzodiazepine agonists diazepam, flunitrazepam, alprazolam, chlordiazepoxide, lorazepam, flurazepam, bromazepam, medazepam, and clorazepate produced dose-related increases in punished responding, and, with the exception of medazepam, decreased unpunished responding at higher doses. Potencies calculated from the percentage of pigeons showing significant increases in punished responding ranged from 0.081 to 11 mg/kg, and these potencies were invariably lower than those for decreases in unpunished responding by factors ranging from 2.2 to more than 14. The comparison of relative potencies of benzodiazepine receptor agonists in pigeons and humans revealed a high positive correlation (0.90, P<0.005), thus demonstrating the predictive validity of this preclinical animal model for anxiolytic benzodiazepines. The results agree with previous findings of robust anticonflict effects of benzodiazepine receptor agonists and extend further the pharmacological characterization to compounds that have not been examined previously in pigeons.",
keywords = "Anxiolytic, Conflict behavior, Pigeon",
author = "Kleven, {Mark S.} and Wouter Koek",
year = "1999",
doi = "10.1007/s002130050826",
language = "English (US)",
volume = "141",
pages = "206--212",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans

AU - Kleven, Mark S.

AU - Koek, Wouter

PY - 1999

Y1 - 1999

N2 - Anxiolytic drugs generally produce anticonflict effects in both pigeons and rats, although relatively few anxiolytics have been examined in the pigeon and the procedure has not been as completely validated as the rat model. In this study, we examined the antipunishment effects of a variety of benzodiazepine agonists in pigeons and compared the relationship between their potencies to engender anxiolytic-like effects and their clinical doses in humans. In pigeons whose responding was maintained under a multiple FR30(food): FR30(foot+shock) schedule, the benzodiazepine agonists diazepam, flunitrazepam, alprazolam, chlordiazepoxide, lorazepam, flurazepam, bromazepam, medazepam, and clorazepate produced dose-related increases in punished responding, and, with the exception of medazepam, decreased unpunished responding at higher doses. Potencies calculated from the percentage of pigeons showing significant increases in punished responding ranged from 0.081 to 11 mg/kg, and these potencies were invariably lower than those for decreases in unpunished responding by factors ranging from 2.2 to more than 14. The comparison of relative potencies of benzodiazepine receptor agonists in pigeons and humans revealed a high positive correlation (0.90, P<0.005), thus demonstrating the predictive validity of this preclinical animal model for anxiolytic benzodiazepines. The results agree with previous findings of robust anticonflict effects of benzodiazepine receptor agonists and extend further the pharmacological characterization to compounds that have not been examined previously in pigeons.

AB - Anxiolytic drugs generally produce anticonflict effects in both pigeons and rats, although relatively few anxiolytics have been examined in the pigeon and the procedure has not been as completely validated as the rat model. In this study, we examined the antipunishment effects of a variety of benzodiazepine agonists in pigeons and compared the relationship between their potencies to engender anxiolytic-like effects and their clinical doses in humans. In pigeons whose responding was maintained under a multiple FR30(food): FR30(foot+shock) schedule, the benzodiazepine agonists diazepam, flunitrazepam, alprazolam, chlordiazepoxide, lorazepam, flurazepam, bromazepam, medazepam, and clorazepate produced dose-related increases in punished responding, and, with the exception of medazepam, decreased unpunished responding at higher doses. Potencies calculated from the percentage of pigeons showing significant increases in punished responding ranged from 0.081 to 11 mg/kg, and these potencies were invariably lower than those for decreases in unpunished responding by factors ranging from 2.2 to more than 14. The comparison of relative potencies of benzodiazepine receptor agonists in pigeons and humans revealed a high positive correlation (0.90, P<0.005), thus demonstrating the predictive validity of this preclinical animal model for anxiolytic benzodiazepines. The results agree with previous findings of robust anticonflict effects of benzodiazepine receptor agonists and extend further the pharmacological characterization to compounds that have not been examined previously in pigeons.

KW - Anxiolytic

KW - Conflict behavior

KW - Pigeon

UR - http://www.scopus.com/inward/record.url?scp=0032899311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032899311&partnerID=8YFLogxK

U2 - 10.1007/s002130050826

DO - 10.1007/s002130050826

M3 - Article

C2 - 9952046

AN - SCOPUS:0032899311

VL - 141

SP - 206

EP - 212

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -